Projected Healthcare System Cost Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in Canada

Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease worldwide. The current and projected cost of treating individuals with MASLD in Canada remains unknown. Our objective was to calculate the projected liver-specific...

Full description

Bibliographic Details

Published in:	Gastro Hep Advances
Main Authors:	K. Ally Memedovich, Abdel Aziz Shaheen, Mark G. Swain, Fiona M. Clement
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Nonalcoholic Fatty Liver Disease Metabolic Dysfunction-Associated Steatotic Liver Disease Health-care Cost Prevalence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772572324000785